CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
3.7.Value Chain Analysis
3.8.Regulatory Guidelines
3.9.Market Share Analysis
3.10.Key Regulation Analysis
3.11.Patent Landscape
CHAPTER 4: WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 In Vivo
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 In Vitro
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE
5.1 Overview
5.1.1 Market size and forecast
5.2 Consumables
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Instruments
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Services
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN
6.1 Overview
6.1.1 Market size and forecast
6.2 Inhaled Allergens
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Food Allergens
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Drug Allergens
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Other Allergens
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
CHAPTER 7: WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Diagnostic Laboratories
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Hospital-based Laboratories
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Academic Research Institutes
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country
7.5 Others
7.5.1 Key market trends, growth factors and opportunities
7.5.2 Market size and forecast, by region
7.5.3 Market analysis by country
CHAPTER 8: WORLD ALLERGY DIAGNOSTIC MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Test Type
8.2.3 North America Market size and forecast, by Product & Service
8.2.4 North America Market size and forecast, by Allergen
8.2.5 North America Market size and forecast, by End-user
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Test Type
8.2.6.1.2 Market size and forecast, by Product & Service
8.2.6.1.3 Market size and forecast, by Allergen
8.2.6.1.4 Market size and forecast, by End-user
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Test Type
8.2.6.2.2 Market size and forecast, by Product & Service
8.2.6.2.3 Market size and forecast, by Allergen
8.2.6.2.4 Market size and forecast, by End-user
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Test Type
8.2.6.3.2 Market size and forecast, by Product & Service
8.2.6.3.3 Market size and forecast, by Allergen
8.2.6.3.4 Market size and forecast, by End-user
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Test Type
8.3.3 Europe Market size and forecast, by Product & Service
8.3.4 Europe Market size and forecast, by Allergen
8.3.5 Europe Market size and forecast, by End-user
8.3.6 Europe Market size and forecast, by country
8.3.6.1 Germany
8.3.6.1.1 Market size and forecast, by Test Type
8.3.6.1.2 Market size and forecast, by Product & Service
8.3.6.1.3 Market size and forecast, by Allergen
8.3.6.1.4 Market size and forecast, by End-user
8.3.6.2 UK
8.3.6.2.1 Market size and forecast, by Test Type
8.3.6.2.2 Market size and forecast, by Product & Service
8.3.6.2.3 Market size and forecast, by Allergen
8.3.6.2.4 Market size and forecast, by End-user
8.3.6.3 France
8.3.6.3.1 Market size and forecast, by Test Type
8.3.6.3.2 Market size and forecast, by Product & Service
8.3.6.3.3 Market size and forecast, by Allergen
8.3.6.3.4 Market size and forecast, by End-user
8.3.6.4 Spain
8.3.6.4.1 Market size and forecast, by Test Type
8.3.6.4.2 Market size and forecast, by Product & Service
8.3.6.4.3 Market size and forecast, by Allergen
8.3.6.4.4 Market size and forecast, by End-user
8.3.6.5 Italy
8.3.6.5.1 Market size and forecast, by Test Type
8.3.6.5.2 Market size and forecast, by Product & Service
8.3.6.5.3 Market size and forecast, by Allergen
8.3.6.5.4 Market size and forecast, by End-user
8.3.6.6 Rest of Europe
8.3.6.6.1 Market size and forecast, by Test Type
8.3.6.6.2 Market size and forecast, by Product & Service
8.3.6.6.3 Market size and forecast, by Allergen
8.3.6.6.4 Market size and forecast, by End-user
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Test Type
8.4.3 Asia-Pacific Market size and forecast, by Product & Service
8.4.4 Asia-Pacific Market size and forecast, by Allergen
8.4.5 Asia-Pacific Market size and forecast, by End-user
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 China
8.4.6.1.1 Market size and forecast, by Test Type
8.4.6.1.2 Market size and forecast, by Product & Service
8.4.6.1.3 Market size and forecast, by Allergen
8.4.6.1.4 Market size and forecast, by End-user
8.4.6.2 Japan
8.4.6.2.1 Market size and forecast, by Test Type
8.4.6.2.2 Market size and forecast, by Product & Service
8.4.6.2.3 Market size and forecast, by Allergen
8.4.6.2.4 Market size and forecast, by End-user
8.4.6.3 India
8.4.6.3.1 Market size and forecast, by Test Type
8.4.6.3.2 Market size and forecast, by Product & Service
8.4.6.3.3 Market size and forecast, by Allergen
8.4.6.3.4 Market size and forecast, by End-user
8.4.6.4 South Korea
8.4.6.4.1 Market size and forecast, by Test Type
8.4.6.4.2 Market size and forecast, by Product & Service
8.4.6.4.3 Market size and forecast, by Allergen
8.4.6.4.4 Market size and forecast, by End-user
8.4.6.5 Australia
8.4.6.5.1 Market size and forecast, by Test Type
8.4.6.5.2 Market size and forecast, by Product & Service
8.4.6.5.3 Market size and forecast, by Allergen
8.4.6.5.4 Market size and forecast, by End-user
8.4.6.6 Rest of Asia-Pacific
8.4.6.6.1 Market size and forecast, by Test Type
8.4.6.6.2 Market size and forecast, by Product & Service
8.4.6.6.3 Market size and forecast, by Allergen
8.4.6.6.4 Market size and forecast, by End-user
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Test Type
8.5.3 LAMEA Market size and forecast, by Product & Service
8.5.4 LAMEA Market size and forecast, by Allergen
8.5.5 LAMEA Market size and forecast, by End-user
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Brazil
8.5.6.1.1 Market size and forecast, by Test Type
8.5.6.1.2 Market size and forecast, by Product & Service
8.5.6.1.3 Market size and forecast, by Allergen
8.5.6.1.4 Market size and forecast, by End-user
8.5.6.2 Saudi Arabia
8.5.6.2.1 Market size and forecast, by Test Type
8.5.6.2.2 Market size and forecast, by Product & Service
8.5.6.2.3 Market size and forecast, by Allergen
8.5.6.2.4 Market size and forecast, by End-user
8.5.6.3 United Arab Emirates
8.5.6.3.1 Market size and forecast, by Test Type
8.5.6.3.2 Market size and forecast, by Product & Service
8.5.6.3.3 Market size and forecast, by Allergen
8.5.6.3.4 Market size and forecast, by End-user
8.5.6.4 South Africa
8.5.6.4.1 Market size and forecast, by Test Type
8.5.6.4.2 Market size and forecast, by Product & Service
8.5.6.4.3 Market size and forecast, by Allergen
8.5.6.4.4 Market size and forecast, by End-user
8.5.6.5 Rest of LAMEA
8.5.6.5.1 Market size and forecast, by Test Type
8.5.6.5.2 Market size and forecast, by Product & Service
8.5.6.5.3 Market size and forecast, by Allergen
8.5.6.5.4 Market size and forecast, by End-user
CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments
CHAPTER 10: COMPANY PROFILES
10.1 Alerchek Inc.
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 Danaher Corp
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Hitachi chemical Diagnostic Inc.
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 HOB Biotech Group Co. Ltd.
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 Hycor Biomedical Inc.
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 Lincoln Diagnostics Inc.
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 Omega Diagnostic Llc
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 Siemens Healthcare Diagnostics, Inc.
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 Stallergenes SA
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 Thermo Fisher Scientific Inc.
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments
10.11 Thermo Fisher Scientific Inc.
10.11.1 Company overview
10.11.2 Company snapshot
10.11.3 Operating business segments
10.11.4 Product portfolio
10.11.5 Business performance
10.11.6 Key strategic moves and developments
10.12 Danaher
10.12.1 Company overview
10.12.2 Company snapshot
10.12.3 Operating business segments
10.12.4 Product portfolio
10.12.5 Business performance
10.12.6 Key strategic moves and developments
10.13 Omega Diagnostics Group PLC
10.13.1 Company overview
10.13.2 Company snapshot
10.13.3 Operating business segments
10.13.4 Product portfolio
10.13.5 Business performance
10.13.6 Key strategic moves and developments
10.14 Eurofins Scientific
10.14.1 Company overview
10.14.2 Company snapshot
10.14.3 Operating business segments
10.14.4 Product portfolio
10.14.5 Business performance
10.14.6 Key strategic moves and developments
10.15 bioMérieux SA
10.15.1 Company overview
10.15.2 Company snapshot
10.15.3 Operating business segments
10.15.4 Product portfolio
10.15.5 Business performance
10.15.6 Key strategic moves and developments
10.16 HollisterStier Allergy
10.16.1 Company overview
10.16.2 Company snapshot
10.16.3 Operating business segments
10.16.4 Product portfolio
10.16.5 Business performance
10.16.6 Key strategic moves and developments
10.17 Minaris Medical America, Inc.
10.17.1 Company overview
10.17.2 Company snapshot
10.17.3 Operating business segments
10.17.4 Product portfolio
10.17.5 Business performance
10.17.6 Key strategic moves and developments
10.18 ACON Laboratories, Inc.
10.18.1 Company overview
10.18.2 Company snapshot
10.18.3 Operating business segments
10.18.4 Product portfolio
10.18.5 Business performance
10.18.6 Key strategic moves and developments
10.19 Lincoln Diagnostics, Inc.
10.19.1 Company overview
10.19.2 Company snapshot
10.19.3 Operating business segments
10.19.4 Product portfolio
10.19.5 Business performance
10.19.6 Key strategic moves and developments
10.20 Neogen Corporation
10.20.1 Company overview
10.20.2 Company snapshot
10.20.3 Operating business segments
10.20.4 Product portfolio
10.20.5 Business performance
10.20.6 Key strategic moves and developments
TABLE 1. GLOBAL WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 2. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR IN VIVO, BY REGION, 2021-2031 ($MILLION)
TABLE 3. WORLD ALLERGY DIAGNOSTIC MARKET FOR IN VIVO, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR IN VITRO, BY REGION, 2021-2031 ($MILLION)
TABLE 5. WORLD ALLERGY DIAGNOSTIC MARKET FOR IN VITRO, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 6. GLOBAL WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 7. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR CONSUMABLES, BY REGION, 2021-2031 ($MILLION)
TABLE 8. WORLD ALLERGY DIAGNOSTIC MARKET FOR CONSUMABLES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 9. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR INSTRUMENTS, BY REGION, 2021-2031 ($MILLION)
TABLE 10. WORLD ALLERGY DIAGNOSTIC MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 11. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR SERVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 12. WORLD ALLERGY DIAGNOSTIC MARKET FOR SERVICES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 13. GLOBAL WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 14. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR INHALED ALLERGENS, BY REGION, 2021-2031 ($MILLION)
TABLE 15. WORLD ALLERGY DIAGNOSTIC MARKET FOR INHALED ALLERGENS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 16. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR FOOD ALLERGENS, BY REGION, 2021-2031 ($MILLION)
TABLE 17. WORLD ALLERGY DIAGNOSTIC MARKET FOR FOOD ALLERGENS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 18. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR DRUG ALLERGENS, BY REGION, 2021-2031 ($MILLION)
TABLE 19. WORLD ALLERGY DIAGNOSTIC MARKET FOR DRUG ALLERGENS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 20. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR OTHER ALLERGENS, BY REGION, 2021-2031 ($MILLION)
TABLE 21. WORLD ALLERGY DIAGNOSTIC MARKET FOR OTHER ALLERGENS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 22. GLOBAL WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 23. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR DIAGNOSTIC LABORATORIES, BY REGION, 2021-2031 ($MILLION)
TABLE 24. WORLD ALLERGY DIAGNOSTIC MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 25. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR HOSPITAL-BASED LABORATORIES, BY REGION, 2021-2031 ($MILLION)
TABLE 26. WORLD ALLERGY DIAGNOSTIC MARKET FOR HOSPITAL-BASED LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 27. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2021-2031 ($MILLION)
TABLE 28. WORLD ALLERGY DIAGNOSTIC MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 29. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 30. WORLD ALLERGY DIAGNOSTIC MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 31. WORLD ALLERGY DIAGNOSTIC MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 32. NORTH AMERICA WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 33. NORTH AMERICA WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 34. NORTH AMERICA WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 35. NORTH AMERICA WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 36. NORTH AMERICA WORLD ALLERGY DIAGNOSTIC MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 37. U.S. WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 38. U.S. WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 39. U.S. WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 40. U.S. WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 41. CANADA WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 42. CANADA WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 43. CANADA WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 44. CANADA WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 45. MEXICO WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 46. MEXICO WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 47. MEXICO WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 48. MEXICO WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 49. EUROPE WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 50. EUROPE WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 51. EUROPE WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 52. EUROPE WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 53. EUROPE WORLD ALLERGY DIAGNOSTIC MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 54. GERMANY WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 55. GERMANY WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 56. GERMANY WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 57. GERMANY WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 58. UK WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 59. UK WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 60. UK WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 61. UK WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 62. FRANCE WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 63. FRANCE WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 64. FRANCE WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 65. FRANCE WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 66. SPAIN WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 67. SPAIN WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 68. SPAIN WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 69. SPAIN WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 70. ITALY WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 71. ITALY WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 72. ITALY WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 73. ITALY WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 74. REST OF EUROPE WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 75. REST OF EUROPE WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 76. REST OF EUROPE WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 77. REST OF EUROPE WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 78. ASIA-PACIFIC WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 79. ASIA-PACIFIC WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 80. ASIA-PACIFIC WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 81. ASIA-PACIFIC WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 82. ASIA-PACIFIC WORLD ALLERGY DIAGNOSTIC MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 83. CHINA WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 84. CHINA WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 85. CHINA WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 86. CHINA WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 87. JAPAN WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 88. JAPAN WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 89. JAPAN WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 90. JAPAN WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 91. INDIA WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 92. INDIA WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 93. INDIA WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 94. INDIA WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 95. SOUTH KOREA WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 96. SOUTH KOREA WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 97. SOUTH KOREA WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 98. SOUTH KOREA WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 99. AUSTRALIA WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 100. AUSTRALIA WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 101. AUSTRALIA WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 102. AUSTRALIA WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 103. REST OF ASIA-PACIFIC WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 104. REST OF ASIA-PACIFIC WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 105. REST OF ASIA-PACIFIC WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 106. REST OF ASIA-PACIFIC WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 107. LAMEA WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 108. LAMEA WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 109. LAMEA WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 110. LAMEA WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 111. LAMEA WORLD ALLERGY DIAGNOSTIC MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 112. BRAZIL WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 113. BRAZIL WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 114. BRAZIL WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 115. BRAZIL WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 116. SAUDI ARABIA WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 117. SAUDI ARABIA WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 118. SAUDI ARABIA WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 119. SAUDI ARABIA WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 120. UNITED ARAB EMIRATES WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 121. UNITED ARAB EMIRATES WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 122. UNITED ARAB EMIRATES WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 123. UNITED ARAB EMIRATES WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 124. SOUTH AFRICA WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 125. SOUTH AFRICA WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 126. SOUTH AFRICA WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 127. SOUTH AFRICA WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 128. REST OF LAMEA WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 129. REST OF LAMEA WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 130. REST OF LAMEA WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 131. REST OF LAMEA WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 132.ALERCHEK INC.: COMPANY SNAPSHOT
TABLE 133.ALERCHEK INC.: OPERATING SEGMENTS
TABLE 134.ALERCHEK INC.: PRODUCT PORTFOLIO
TABLE 135.ALERCHEK INC.: NET SALES,
TABLE 136.ALERCHEK INC.: KEY STRATERGIES
TABLE 137.DANAHER CORP: COMPANY SNAPSHOT
TABLE 138.DANAHER CORP: OPERATING SEGMENTS
TABLE 139.DANAHER CORP: PRODUCT PORTFOLIO
TABLE 140.DANAHER CORP: NET SALES,
TABLE 141.DANAHER CORP: KEY STRATERGIES
TABLE 142.HITACHI CHEMICAL DIAGNOSTIC INC.: COMPANY SNAPSHOT
TABLE 143.HITACHI CHEMICAL DIAGNOSTIC INC.: OPERATING SEGMENTS
TABLE 144.HITACHI CHEMICAL DIAGNOSTIC INC.: PRODUCT PORTFOLIO
TABLE 145.HITACHI CHEMICAL DIAGNOSTIC INC.: NET SALES,
TABLE 146.HITACHI CHEMICAL DIAGNOSTIC INC.: KEY STRATERGIES
TABLE 147.HOB BIOTECH GROUP CO. LTD.: COMPANY SNAPSHOT
TABLE 148.HOB BIOTECH GROUP CO. LTD.: OPERATING SEGMENTS
TABLE 149.HOB BIOTECH GROUP CO. LTD.: PRODUCT PORTFOLIO
TABLE 150.HOB BIOTECH GROUP CO. LTD.: NET SALES,
TABLE 151.HOB BIOTECH GROUP CO. LTD.: KEY STRATERGIES
TABLE 152.HYCOR BIOMEDICAL INC.: COMPANY SNAPSHOT
TABLE 153.HYCOR BIOMEDICAL INC.: OPERATING SEGMENTS
TABLE 154.HYCOR BIOMEDICAL INC.: PRODUCT PORTFOLIO
TABLE 155.HYCOR BIOMEDICAL INC.: NET SALES,
TABLE 156.HYCOR BIOMEDICAL INC.: KEY STRATERGIES
TABLE 157.LINCOLN DIAGNOSTICS INC.: COMPANY SNAPSHOT
TABLE 158.LINCOLN DIAGNOSTICS INC.: OPERATING SEGMENTS
TABLE 159.LINCOLN DIAGNOSTICS INC.: PRODUCT PORTFOLIO
TABLE 160.LINCOLN DIAGNOSTICS INC.: NET SALES,
TABLE 161.LINCOLN DIAGNOSTICS INC.: KEY STRATERGIES
TABLE 162.OMEGA DIAGNOSTIC LLC: COMPANY SNAPSHOT
TABLE 163.OMEGA DIAGNOSTIC LLC: OPERATING SEGMENTS
TABLE 164.OMEGA DIAGNOSTIC LLC: PRODUCT PORTFOLIO
TABLE 165.OMEGA DIAGNOSTIC LLC: NET SALES,
TABLE 166.OMEGA DIAGNOSTIC LLC: KEY STRATERGIES
TABLE 167.SIEMENS HEALTHCARE DIAGNOSTICS, INC.: COMPANY SNAPSHOT
TABLE 168.SIEMENS HEALTHCARE DIAGNOSTICS, INC.: OPERATING SEGMENTS
TABLE 169.SIEMENS HEALTHCARE DIAGNOSTICS, INC.: PRODUCT PORTFOLIO
TABLE 170.SIEMENS HEALTHCARE DIAGNOSTICS, INC.: NET SALES,
TABLE 171.SIEMENS HEALTHCARE DIAGNOSTICS, INC.: KEY STRATERGIES
TABLE 172.STALLERGENES SA: COMPANY SNAPSHOT
TABLE 173.STALLERGENES SA: OPERATING SEGMENTS
TABLE 174.STALLERGENES SA: PRODUCT PORTFOLIO
TABLE 175.STALLERGENES SA: NET SALES,
TABLE 176.STALLERGENES SA: KEY STRATERGIES
TABLE 177.THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
TABLE 178.THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
TABLE 179.THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
TABLE 180.THERMO FISHER SCIENTIFIC INC.: NET SALES,
TABLE 181.THERMO FISHER SCIENTIFIC INC.: KEY STRATERGIES
TABLE 182.THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
TABLE 183.THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
TABLE 184.THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
TABLE 185.THERMO FISHER SCIENTIFIC INC.: NET SALES,
TABLE 186.THERMO FISHER SCIENTIFIC INC.: KEY STRATERGIES
TABLE 187.DANAHER: COMPANY SNAPSHOT
TABLE 188.DANAHER: OPERATING SEGMENTS
TABLE 189.DANAHER: PRODUCT PORTFOLIO
TABLE 190.DANAHER: NET SALES,
TABLE 191.DANAHER: KEY STRATERGIES
TABLE 192.OMEGA DIAGNOSTICS GROUP PLC: COMPANY SNAPSHOT
TABLE 193.OMEGA DIAGNOSTICS GROUP PLC: OPERATING SEGMENTS
TABLE 194.OMEGA DIAGNOSTICS GROUP PLC: PRODUCT PORTFOLIO
TABLE 195.OMEGA DIAGNOSTICS GROUP PLC: NET SALES,
TABLE 196.OMEGA DIAGNOSTICS GROUP PLC: KEY STRATERGIES
TABLE 197.EUROFINS SCIENTIFIC: COMPANY SNAPSHOT
TABLE 198.EUROFINS SCIENTIFIC: OPERATING SEGMENTS
TABLE 199.EUROFINS SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 200.EUROFINS SCIENTIFIC: NET SALES,
TABLE 201.EUROFINS SCIENTIFIC: KEY STRATERGIES
TABLE 202.BIOMÉRIEUX SA: COMPANY SNAPSHOT
TABLE 203.BIOMÉRIEUX SA: OPERATING SEGMENTS
TABLE 204.BIOMÉRIEUX SA: PRODUCT PORTFOLIO
TABLE 205.BIOMÉRIEUX SA: NET SALES,
TABLE 206.BIOMÉRIEUX SA: KEY STRATERGIES
TABLE 207.HOLLISTERSTIER ALLERGY: COMPANY SNAPSHOT
TABLE 208.HOLLISTERSTIER ALLERGY: OPERATING SEGMENTS
TABLE 209.HOLLISTERSTIER ALLERGY: PRODUCT PORTFOLIO
TABLE 210.HOLLISTERSTIER ALLERGY: NET SALES,
TABLE 211.HOLLISTERSTIER ALLERGY: KEY STRATERGIES
TABLE 212.MINARIS MEDICAL AMERICA, INC.: COMPANY SNAPSHOT
TABLE 213.MINARIS MEDICAL AMERICA, INC.: OPERATING SEGMENTS
TABLE 214.MINARIS MEDICAL AMERICA, INC.: PRODUCT PORTFOLIO
TABLE 215.MINARIS MEDICAL AMERICA, INC.: NET SALES,
TABLE 216.MINARIS MEDICAL AMERICA, INC.: KEY STRATERGIES
TABLE 217.ACON LABORATORIES, INC.: COMPANY SNAPSHOT
TABLE 218.ACON LABORATORIES, INC.: OPERATING SEGMENTS
TABLE 219.ACON LABORATORIES, INC.: PRODUCT PORTFOLIO
TABLE 220.ACON LABORATORIES, INC.: NET SALES,
TABLE 221.ACON LABORATORIES, INC.: KEY STRATERGIES
TABLE 222.LINCOLN DIAGNOSTICS, INC.: COMPANY SNAPSHOT
TABLE 223.LINCOLN DIAGNOSTICS, INC.: OPERATING SEGMENTS
TABLE 224.LINCOLN DIAGNOSTICS, INC.: PRODUCT PORTFOLIO
TABLE 225.LINCOLN DIAGNOSTICS, INC.: NET SALES,
TABLE 226.LINCOLN DIAGNOSTICS, INC.: KEY STRATERGIES
TABLE 227.NEOGEN CORPORATION: COMPANY SNAPSHOT
TABLE 228.NEOGEN CORPORATION: OPERATING SEGMENTS
TABLE 229.NEOGEN CORPORATION: PRODUCT PORTFOLIO
TABLE 230.NEOGEN CORPORATION: NET SALES,
TABLE 231.NEOGEN CORPORATION: KEY STRATERGIES
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
